Clinical trial details

Phase I/Ib trial of OST-122 in cancer patients with advanced solid tumors

Identifier

CT-OST-499-01

Sponsor

ONCOSTELLAE

Principal Investigator

GUZMAN ALONSO CASAL

Service

Oncology

Study details

Tumor type: ALL SOLID TUMORS
Stage: Advanced
Main Investigational Agent : Targeted therapy
Phase: I
Randomization: Non-randomized

Molecular details

Biomarker: Not applicable
Biomarker criteria: Not applicable
Prescreening: Not applicable
Additional study population requirements: Not applicable

Drug details

Arm A: OST-499

Links

Clinical Trials GOV (NCT identifier): NL
EU Clinical Trials Register (eudraCT Identifier): 2021-003728-34